Erik Hyypia

100%

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

No current examples available.

Conflicts of Interest

No current examples available.

Contradictions

No current examples available.

Deceptions

No current examples available.

Recent Articles

New TB Vaccine Trial Brings Hope to End the Pandemic in South Africa and Beyond

New TB Vaccine Trial Brings Hope to End the Pandemic in South Africa and Beyond

Broke On: Tuesday, 19 March 2024 The Gates MRI has initiated a Phase 3 clinical trial to evaluate the effectiveness of the M72/AS01E vaccine candidate in protecting adolescents and adults from pulmonary tuberculosis. If successful, it could be the first new TB vaccine in over a century. The trial is significant as it brings hope for ending TB through prevention and early diagnosis.